CTL Medical received FDA 510(k) clearance to market the MATISSE⢠Titanium Anterior Cervical Interbody Fusion cage for useĀ with supplemental fixation, such as the company’s VAN GOGH⢠anterior cervical plate.
MATISSE features CTL’s proprietary TiCro⢠surface technology, which is designed to offer 200% greater endplate contact surface area. The first version of MATISSE received its clearance in 2012 under AccelSPINE, which was acquired by CTL in 1Q16.
Sources: CTL Medical Corporation; ORTHOWORLD Inc.
CTL Medical received FDA 510(k) clearance to market the MATISSE⢠Titanium Anterior Cervical Interbody Fusion cage for use with supplemental fixation, such as the company's VAN GOGH⢠anterior cervical plate.
MATISSE features CTL's proprietary TiCro⢠surface technology, which is designed to offer 200% greater endplate contact...
CTL Medical received FDA 510(k) clearance to market the MATISSE⢠Titanium Anterior Cervical Interbody Fusion cage for useĀ with supplemental fixation, such as the company’s VAN GOGH⢠anterior cervical plate.
MATISSE features CTL’s proprietary TiCro⢠surface technology, which is designed to offer 200% greater endplate contact surface area. The first version of MATISSE received its clearance in 2012 under AccelSPINE, which was acquired by CTL in 1Q16.
Sources: CTL Medical Corporation; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.